Harsch Mutya (CIK 1727809) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell VYNE (3,464 shares), Sell VYNE (4,007 shares), Sell VYNE (3,579 shares), Sell VYNE (3,581 shares), Sell VYNE (3,581 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF LEGAL OFFICER AND GC | Sell | 3,464 | $2,254 |
| 2026-04-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF LEGAL OFFICER AND GC | Sell | 4,007 | $2,394 |
| 2026-01-05 | VYNE Therapeutics Inc. (VYNE) | CHIEF LEGAL OFFICER AND GC | Sell | 3,579 | $2,076 |
| 2025-10-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF LEGAL OFFICER AND GC | Sell | 3,581 | $1,218 |
| 2025-07-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF LEGAL OFFICER AND GC | Sell | 3,581 | $5,909 |
| 2025-06-03 | VYNE Therapeutics Inc. (VYNE) | CHIEF LEGAL OFFICER AND GC | Buy | 1,145 | $927 |
| 2025-04-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF LEGAL OFFICER AND GC | Sell | 8,828 | $13,948 |
Source: SEC Form 4 filings · as of 2026-07-02